Thrilled to receive NIH funding for our global trial (Global PPCM) of bromocriptine for peripartum cardiomyopathy, a major cause of maternal mortality! Grateful to the NIH and our partners in the US and worldwide for their steadfast collaboration over the past 6 years. Onward!
A new international trial, GLOBal PPCM, coordinated through MHIGH and the Center for Research in Women's Health, will test whether a widely available drug can save the lives of mothers with peripartum cardiomyopathy.View quoted post on X
uab.edu/medicine/news/…